Literature DB >> 12896894

Assessment for deaths in out-of-hospital heroin overdose patients treated with naloxone who refuse transport.

Gary M Vilke1, Christian Sloane, Alan M Smith, Theodore C Chan.   

Abstract

UNLABELLED: Naloxone frequently is used to treat suspected heroin and opioid overdoses in the out-of-hospital setting. The authors' emergency medical services system has operated a policy of allowing these patients, when successfully treated, to sign out against medical advice (AMA) in the field.
OBJECTIVES: To evaluate the safety of this AMA policy.
METHODS: This is a retrospective review of out-of-hospital and medical examiner (ME) databases over a five-year period. The authors reviewed all ME cases in which opioid overdoses were listed as contributing to the cause of death. These cases were cross-compared with all patients who received naloxone by field paramedics and then refused transport. The charts were reviewed by dates, times, age, sex, location, and ethnicity when available.
RESULTS: There were 998 out-of-hospital patients who received naloxone and refused further treatment and 601 ME cases of opioid overdose deaths. When compared by age, time, date, sex, location, and ethnicity, there were no cases in which a patient was treated by paramedics with naloxone within 12 hours of being found dead of an opioid overdose.
CONCLUSIONS: Giving naloxone to patients with heroin overdoses in the field and then allowing them to sign out AMA resulted in no identifiable deaths within this study population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12896894     DOI: 10.1111/j.1553-2712.2003.tb00636.x

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  21 in total

Review 1.  Naloxone dosage for opioid reversal: current evidence and clinical implications.

Authors:  Rachael Rzasa Lynn; J L Galinkin
Journal:  Ther Adv Drug Saf       Date:  2017-12-13

2.  Disparity in naloxone administration by emergency medical service providers and the burden of drug overdose in US rural communities.

Authors:  Mark Faul; Michael W Dailey; David E Sugerman; Scott M Sasser; Benjamin Levy; Len J Paulozzi
Journal:  Am J Public Health       Date:  2015-04-23       Impact factor: 9.308

Review 3.  Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access.

Authors:  Daniel P Wermeling
Journal:  Ther Adv Drug Saf       Date:  2015-02

4.  Expanding access to naloxone in the United States.

Authors:  Suzanne Doyon; Steven E Aks; Scott Schaeffer
Journal:  J Med Toxicol       Date:  2014-12

5.  Overdose Research: 15 Years Later.

Authors:  Phillip O Coffin; Josiah D Rich
Journal:  J Urban Health       Date:  2019-02       Impact factor: 3.671

Review 6.  Flumazenil, naloxone and the 'coma cocktail'.

Authors:  Marco L A Sivilotti
Journal:  Br J Clin Pharmacol       Date:  2015-09-21       Impact factor: 4.335

7.  Location of fatal prescription opioid-related deaths in 12 states, 2008-2010: Implications for prevention programs.

Authors:  Keith W Easterling; Karin A Mack; Christopher M Jones
Journal:  J Safety Res       Date:  2016-08-07

8.  Pitfalls of intranasal naloxone.

Authors:  Matthew Zuckerman; Stacy N Weisberg; Edward W Boyer
Journal:  Prehosp Emerg Care       Date:  2014-05-15       Impact factor: 3.077

9.  Pre-hospital treatment of acute poisonings in Oslo.

Authors:  Fridtjof Heyerdahl; Knut E Hovda; Mari A Bjornaas; Anne K Nore; Jose C P Figueiredo; Oivind Ekeberg; Dag Jacobsen
Journal:  BMC Emerg Med       Date:  2008-11-24

10.  Opportunities for Emergency Medical Services Intervention to Prevent Opioid Overdose Mortality.

Authors:  Elizabeth H Barefoot; Julianne M Cyr; Jane H Brice; Michael W Bachman; Jefferson G Williams; Jose G Cabanas; Kyle M Herbert
Journal:  Prehosp Emerg Care       Date:  2020-04-02       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.